{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T05:06:36Z","timestamp":1712898396841},"reference-count":41,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":185,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Sciences Foundation of China","doi-asserted-by":"crossref","award":["32070677"],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,5]]},"abstract":"Abstract<\/jats:title>\n Lymphoma is a heterogeneous disease caused by malignant proliferation of lymphocytes, resulting in significant mortality worldwide. While more and more lymphoma biomarkers have been identified with the advent and development of precision medicine, there are currently no databases dedicated to systematically gathering these scattered treasures. Therefore, we developed a lymphoma biomarker database (LBD) to curate experimentally validated lymphoma biomarkers in this study. LBD consists of 793 biomarkers extracted from 978 articles covering diverse subtypes of lymphomas, including 715 single and 78 combined biomarkers. These biomarkers can be categorized into molecular, cellular, image, histopathological, physiological and other biomarkers with various functions such as prognosis, diagnosis and treatment. As a manually curated database that provides comprehensive information about lymphoma biomarkers, LBD is helpful for personalized diagnosis and treatment of lymphoma.<\/jats:p>\n Database URL<\/jats:p>\n http:\/\/bis.zju.edu.cn\/LBD<\/jats:p>","DOI":"10.1093\/database\/baac051","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T12:26:49Z","timestamp":1657024009000},"source":"Crossref","is-referenced-by-count":2,"title":["LBD: a manually curated database of experimentally validated lymphoma biomarkers"],"prefix":"10.1093","volume":"2022","author":[{"given":"Bin","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Bioinformatics, College of Life Sciences, Zhejiang University , Hangzhou 310058, China"}]},{"given":"Saige","family":"Xin","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, College of Life Sciences, Zhejiang University , Hangzhou 310058, China"}]},{"ORCID":"http:\/\/orcid.org\/0000-0003-3219-3778","authenticated-orcid":false,"given":"Yanshi","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, College of Life Sciences, Zhejiang University , Hangzhou 310058, China"}]},{"given":"Cong","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, College of Life Sciences, Zhejiang University , Hangzhou 310058, China"}]},{"ORCID":"http:\/\/orcid.org\/0000-0002-9677-1699","authenticated-orcid":false,"given":"Ming","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, College of Life Sciences, Zhejiang University , Hangzhou 310058, China"},{"name":"Biomedical Big Data Center, the First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou 310003, China"},{"name":"Institute of Hematology, Zhejiang University , Hangzhou 310058, China"}]}],"member":"286","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"2022070512263953900_R1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-pathol-020117-043803","article-title":"New insights into lymphoma pathogenesis","volume":"13","author":"Elenitoba-Johnson","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"2022070512263953900_R2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.seminhematol.2018.05.007","article-title":"Diagnosis and classification of lymphoma: impact of technical advances","volume":"56","author":"Jaffe","year":"2019","journal-title":"Semin. Hematol."},{"key":"2022070512263953900_R3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PPO.0000000000000451","article-title":"Lymphoma classification","volume":"26","author":"de Leval","year":"2020","journal-title":"Cancer J."},{"key":"2022070512263953900_R4","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"2022070512263953900_R5","article-title":"Cancer Incidence and Mortality Statistics Worldwide and by Region","author":"International Agency for Research on Cancer","year":"2020"},{"key":"2022070512263953900_R6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1535-6108(02)00178-2","article-title":"Focus on lymphomas","volume":"2","author":"Staudt","year":"2002","journal-title":"Cancer Cell"},{"key":"2022070512263953900_R7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","article-title":"EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation","volume":"23","author":"B\u00e9guelin","year":"2013","journal-title":"Cancer Cell"},{"key":"2022070512263953900_R8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat. Genet."},{"key":"2022070512263953900_R9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/onc.2013.571","article-title":"Oncogenic Y641 mutations in EZH2 prevent Jak2\/\u03b2-TrCP-mediated degradation","volume":"34","author":"Sahasrabuddhe","year":"2014","journal-title":"Oncogene"},{"key":"2022070512263953900_R10","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"2022070512263953900_R11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Biomarkers Definitions Working, G","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"2022070512263953900_R12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41584-018-0005-9","article-title":"Biomarkers as drug development tools: discovery, validation, qualification and use","volume":"14","author":"Kraus","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"2022070512263953900_R13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"2022070512263953900_R14","first-page":"1101","article-title":"Predictive significance of the cut-off value of CD20 expression in patients with B-cell lymphoma","volume":"24","author":"Horvat","year":"2010","journal-title":"Oncol. Rep."},{"key":"2022070512263953900_R15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrclinonc.2013.197","article-title":"Diffuse large B-cell lymphoma\u2014treatment approaches in the molecular era","volume":"11","author":"Roschewski","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2022070512263953900_R16","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/j.bbagen.2016.02.017","article-title":"dbPHCC: a database of prognostic biomarkers for hepatocellular carcinoma that provides online prognostic modeling","volume":"1860","author":"Ouyang","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"2022070512263953900_R17","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baw059","article-title":"CoReCG: a comprehensive database of genes associated with colon-rectal cancer","volume":"2016","author":"Agarwal","year":"2016","journal-title":"Database (Oxford)"},{"key":"2022070512263953900_R18","doi-asserted-by":"crossref","first-page":"D455","DOI":"10.1093\/nar\/gkm925","article-title":"IDBD: infectious disease biomarker database","volume":"36","author":"Yang","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"2022070512263953900_R19","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.010975","article-title":"A tool for biomarker discovery in the urinary proteome: a manually curated human and animal urine protein biomarker database","volume":"10","author":"Shao","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"2022070512263953900_R20","doi-asserted-by":"crossref","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","article-title":"HMDB 5.0: the human metabolome database for 2022","volume":"50","author":"Wishart","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"2022070512263953900_R21","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"2022070512263953900_R22","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.4049\/jimmunol.181.4.2506","article-title":"\u03b3c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes","volume":"181","author":"Kasprzycka","year":"2008","journal-title":"J. Immunol."},{"key":"2022070512263953900_R23","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1158\/0008-5472.CAN-07-2403","article-title":"Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells","volume":"68","author":"Marzec","year":"2008","journal-title":"Cancer Res."},{"key":"2022070512263953900_R24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI11991","article-title":"Control of oncogenesis and cancer therapy resistance by the transcription factor NF-\u03baB","volume":"107","author":"Baldwin","year":"2001","journal-title":"J. Clin. Invest."},{"key":"2022070512263953900_R25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MOH.0000000000000156","article-title":"The role of aberrant proteolysis in lymphomagenesis","volume":"22","author":"Sahasrabuddhe","year":"2015","journal-title":"Curr. Opin. Hematol."},{"key":"2022070512263953900_R26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tibs.2004.11.009","article-title":"Phosphorylation of NF-\u03baB and I\u03baB proteins: implications in cancer and inflammation","volume":"30","author":"Viatour","year":"2005","journal-title":"Trends Biochem. Sci."},{"key":"2022070512263953900_R27","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-4-2","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"Bader","year":"2003","journal-title":"BMC Bioinform."},{"key":"2022070512263953900_R28","doi-asserted-by":"crossref","first-page":"14304","DOI":"10.3390\/molecules190914304","article-title":"Inhibition of the PI3K\/Akt\/mTOR signaling pathway in diffuse large B-cell lymphoma: current knowledge and clinical significance","volume":"19","author":"Majchrzak","year":"2014","journal-title":"Molecules"},{"key":"2022070512263953900_R29","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-020-01623-w","article-title":"Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K\/Akt signaling","volume":"39","author":"Yang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2022070512263953900_R30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.molimm.2013.10.006","article-title":"Calcium signaling in B cells: regulation of cytosolic Ca2+ increase and its sensor molecules, STIM1 and STIM2","volume":"62","author":"Baba","year":"2014","journal-title":"Mol. Immunol."},{"key":"2022070512263953900_R31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrclinonc.2012.156","article-title":"From drug discovery to biomarker-driven clinical trials in lymphoma","volume":"9","author":"Younes","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2022070512263953900_R32","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00277-009-0870-z","article-title":"The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan","volume":"89","author":"Chen","year":"2009","journal-title":"Ann. Hematol."},{"key":"2022070512263953900_R33","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.hoc.2008.07.008","article-title":"Classification of non-Hodgkin\u2019s lymphoma","volume":"22","author":"Good","year":"2008","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"2022070512263953900_R34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrclinonc.2014.137","article-title":"Precision therapy for lymphoma\u2014current state and future directions","volume":"11","author":"Intlekofer","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2022070512263953900_R35","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.drudis.2017.04.013","article-title":"Mechanism-based biomarker discovery","volume":"22","author":"Antoranz","year":"2017","journal-title":"Drug Discov. Today"},{"key":"2022070512263953900_R36","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/bib\/bbx158","article-title":"Computer-aided biomarker discovery for precision medicine: data resources, models and applications","volume":"20","author":"Lin","year":"2019","journal-title":"Brief. Bioinform."},{"key":"2022070512263953900_R37","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.jid.2019.07.682","article-title":"Research techniques made simple: feature selection for biomarker discovery","volume":"139","author":"Torres","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"2022070512263953900_R38","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2009-08-236471","article-title":"Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia","volume":"115","author":"Friedberg","year":"2010","journal-title":"Blood"},{"key":"2022070512263953900_R39","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nrclinonc.2012.91","article-title":"State of the art in the treatment of Hodgkin lymphoma","volume":"9","author":"Borchmann","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2022070512263953900_R40","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","article-title":"Non-Hodgkin lymphoma","volume":"380","author":"Shankland","year":"2012","journal-title":"Lancet"},{"key":"2022070512263953900_R41","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J. Clin. Oncol."}],"container-title":["Database"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/database\/article-pdf\/doi\/10.1093\/database\/baac051\/44408228\/baac051.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/database\/article-pdf\/doi\/10.1093\/database\/baac051\/44408228\/baac051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T12:27:25Z","timestamp":1657024045000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/database\/article\/doi\/10.1093\/database\/baac051\/6631110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":41,"URL":"https:\/\/doi.org\/10.1093\/database\/baac051","relation":{},"ISSN":["1758-0463"],"issn-type":[{"value":"1758-0463","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2022,1,1]]}}}
